Telomir Pharmaceuticals Inc 2026年季度报告

Form 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________to _______________ Commission File Number 001-41952 Telomir Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Florida87-2606031(State or other jurisdiction of(I.R.S. Employer incorporation or organization)Identification No.) 100 SE 2nd St, Suite 200 #1009Miami, Florida33131(Address of principal executive offices)(Zip Code) Registrant’s telephone number (including area code):(786) 396-6723 Not Applicable(Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Actof 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and“emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of August 12, 2026, there were 68,774,956 shares of the registrant’s common stock issued and outstanding. TABLE OF CONTENTS PageCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS3Part I. Financial Information4Item 1.Condensed Consolidated Financial Statements4Condensed Consolidated Balance Sheets4Condensed Consolidated Statements of Operations (unaudited)5Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (unaudited)6Condensed Consolidated Statements of Cash Flows (unaudited)7Notes to Condensed Consolidated Financial Statements (unaudited)8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations21Item 3.Quantitative and Qualitative Disclosures about Market Risk27Item 4.Controls and Procedures27Part II. Other Information28Item 1Legal Proceedings28Item 1A.Risk Factors28Item 2Unregistered Sales of Equity Securities and Use of Proceeds28Item 3Defaults upon Senior Securities28Item 4Mine Safety Disclosures28Item 5Other Information28Item 6.Exhibits28Signatures302 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements with the meaning of the Private Securities Litigation Reform Act of1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements concerningour business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our futureoperations, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,”“should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential”, or“continue” or the negative of these terms or other similar expressions. In particular, statements about the markets in which we operate,including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events orperformance contained in this Quarterly Report on Form 10-Q are forward-looking statements. We have based these forward-lookingstatements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates,and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties,many of which are beyond our control. These and other important factors may cause our actual results, performance, or achievements to differmaterially from any future results, performance or achievements expressed or implied by these forward-looking statements, o